.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Claims for Patent: 6,245,819

« Back to Dashboard

Claims for Patent: 6,245,819

Title: Method for the treatment of vaginal dryness and sexual dysfunction in women during or after the menopause
Abstract:This invention concerns a method for the treatment of vaginal dryness or sexual dysfunction in women during or after the menopause, said method comprising administering to the woman an effective amount of the compound (deaminohydroxy)toremifene or a pharmaceutically acceptable salt or ester thereof, or a metabolite thereof.
Inventor(s): Halonen; Kaija (Rusko, FI), Kangas; Lauri (Raisio, FI), DeGregorio; Michael W. (Granite Bay, CA)
Assignee: Hormos Medical Oy, Ltd. (FI) Tess Diagnostics and Pharmaceuticals, Inc. (Granite Bay, CA)
Application Number:09/625,199
Patent Claims: 1. A method for the treatment of vaginal dryness or sexual dysfunction in women during or after the menopause, said method comprising administering to the woman an effective amount of the compound (deaminohydroxy)toremifene or a pharmaceutically acceptable salt or ester thereof or metabolite thereof.

2. The method according to claim 1 wherein the compound or its salt or ester is administered in a daily dose varying in the range of 25 to 100 mg.

3. The use according to claim 2 wherein the compound or its salt or ester is administered in a daily dose varying in the range of 30 to 90 mg.

4. The method according to claim 1 wherein the compound or its salt or ester is administered orally or transdermally.

5. The method according to claim 2 wherein the compound or its salt or ester is administered orally or transdermally.

6. The method according to claim 3 wherein the compound or its salt or ester is administered orally or transdermally.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc